Status:
COMPLETED
Intensive Therapy for Children With Microcephaly, Hyperkinetic Movements, or Global Developmental Delay
Lead Sponsor:
Virginia Polytechnic Institute and State University
Collaborating Sponsors:
American Academy of Cerebral Palsy and Developmental Medicine
Conditions:
Microcephaly
Hyperkinesis With Developmental Delay
Eligibility:
All Genders
6-15 years
Phase:
NA
Brief Summary
This trial will consist of a clinical series of up to 50 children with Global Developmental Delay and concomitant microcephaly or hyperkinetic movements. All children will be assessed for psychomotor ...
Detailed Description
Up to 50 children between the ages of 6 months and 15 years will be recruited to participate in a burst of intensive neuromotor intervention in the form of Acquire therapy, delivered by the treatment ...
Eligibility Criteria
Inclusion
- Diagnosis of Global Developmental Delay with Microcephaly or hyperkinetic movements.
Exclusion
- Medical Instability
- Under 6 months of age over 15 years of age
Key Trial Info
Start Date :
April 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 11 2022
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04816175
Start Date
April 30 2019
End Date
August 11 2022
Last Update
October 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fralin Biomedical Research Institute at Virginia Tech
Roanoke, Virginia, United States, 24016